Patents by Inventor Haishan Li

Haishan Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV VACCINATION AND IMMUNOTHERAPY
    Publication number: 20190046633
    Abstract: The present invention relates generally to immunotherapy for preventing HIV infection in HIV-negative individuals. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Application
    Filed: January 11, 2017
    Publication date: February 14, 2019
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen
  • Methods and compositions for the activation of gamma-delta T-cells
    Patent number: 10137144
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: November 27, 2018
    Assignee: American Gene Technologies International Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou
  • METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS
    Publication number: 20180305716
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Application
    Filed: June 14, 2018
    Publication date: October 25, 2018
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou
  • HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
    Publication number: 20180291399
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Application
    Filed: June 18, 2018
    Publication date: October 11, 2018
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS
    Publication number: 20180256624
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Application
    Filed: February 23, 2018
    Publication date: September 13, 2018
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou
  • HIV pre-immunization and immunotherapy
    Patent number: 10036038
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: July 31, 2018
    Assignee: American Gene Technologies International Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • Methods and compositions for the activation of gamma-delta T-cells
    Patent number: 10036040
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: July 31, 2018
    Assignee: American Gene Technologies International Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou
  • Methods and compositions for the activation of gamma-delta T-cells
    Patent number: 10023880
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: July 17, 2018
    Assignee: American Gene Technologies International Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou
  • METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS
    Publication number: 20180142258
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Application
    Filed: December 21, 2017
    Publication date: May 24, 2018
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou
  • METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS
    Publication number: 20180142257
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Application
    Filed: December 20, 2017
    Publication date: May 24, 2018
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou
  • Methods and compositions for the activation of gamma-delta T-cells
    Patent number: 9914938
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: March 13, 2018
    Assignee: American Gene Technologies International, Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou
  • HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
    Publication number: 20180010147
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Application
    Filed: August 3, 2017
    Publication date: January 11, 2018
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen
  • Methods and compositions for the activation of gamma-delta T-cells
    Patent number: 9834790
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: December 5, 2017
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou
  • METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS
    Publication number: 20170335344
    Abstract: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
    Type: Application
    Filed: July 17, 2017
    Publication date: November 23, 2017
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Mei-Ling Liou